+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioactive Glass Implants Market by Material Composition, Application Area, Manufacturing Method, Design Innovation, Performance Characteristics, Regulatory and Research Status - Global Forecast to 2030- Product Image
Bioactive Glass Implants Market by Material Composition, Application Area, Manufacturing Method, Design Innovation, Performance Characteristics, Regulatory and Research Status - Global Forecast to 2030- Product Image
Sale

Bioactive Glass Implants Market by Material Composition, Application Area, Manufacturing Method, Design Innovation, Performance Characteristics, Regulatory and Research Status - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6161032
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Bioactive glass implants are at the forefront of transforming regenerative medicine by facilitating bone repair, dental restoration, and craniofacial reconstruction through their unique ability to bond with living tissues. Over the past decade, advances in material science have refined borate, phosphate, and silicate formulations to optimize bioactivity, resorption rates, and mechanical integrity. As demand grows for solutions that accelerate healing, minimize infection risk, and integrate seamlessly with patient anatomy, bioactive glass technologies have evolved from niche laboratory curiosities into clinically proven therapies. This executive summary provides a concise overview of key market dynamics, structural shifts, regulatory influences, segmentation insights, regional performance, competitive positioning, and strategic imperatives. It aims to equip decision-makers with a clear understanding of current trends and practical guidance to capitalize on emerging opportunities in this rapidly maturing field.

Transformative Shifts Reshaping the Bioactive Glass Implant Landscape

The landscape of bioactive glass implants has experienced several transformative shifts in recent years. First, rapid iterative improvements in three-dimensional printing and sol-gel processing have enabled complex geometries and patient-specific designs that were previously unattainable, significantly enhancing osseointegration and clinical outcomes. Simultaneously, breakthroughs in additive manufacturing have streamlined production workflows, reducing lead times and fostering on-demand customization. At the same time, heightened scrutiny from regulatory authorities has driven manufacturers to adopt rigorous quality management systems and robust preclinical validation, which in turn has elevated industry standards. Furthermore, the integration of antibacterial agents and growth factors into glass matrices has expanded the implants’ functional profile beyond structural support to active promotion of healing and infection control. Finally, strategic collaborations between device developers, academic institutions, and clinical centers have accelerated translation of novel compositions into trial phases, positioning the field for sustained growth as evidence accumulates supporting long-term safety and efficacy.

Cumulative Impact of U.S. Tariffs on Bioactive Glass Implants in 2025

Tariff adjustments imposed by the United States in 2025 have introduced both challenges and strategic levers for bioactive glass implant stakeholders. Increased duties on imported raw materials and finished devices have elevated costs across manufacturing and distribution channels, prompting some suppliers to reassess global sourcing models. In response, several manufacturers have accelerated localization of critical production steps, forging partnerships with domestic glass suppliers to mitigate exposure to cross-border tariffs. At the same time, higher import costs have incentivized investment in vertically integrated operations, where securing in-house melting, milling, and sintering capabilities can shield margins despite trade-related headwinds. Meanwhile, distributors have adjusted pricing strategies and engaged in value-based contracting with healthcare providers to preserve uptake despite constrained purchasing budgets. These cumulative shifts underscore the importance of supply chain agility and proactive stakeholder alignment in navigating evolving trade policies.

Key Segmentation Insights into Bioactive Glass Implant Markets

A comprehensive view of the bioactive glass implant market emerges when it is segmented by material, application, manufacturing, design innovation, performance, and regulatory status. Based on material composition, the landscape spans borate, phosphate, and silicate glasses, with silicate compositions further differentiated by bioactive silicates known for their superior bone-bonding kinetics. When examined by application area, offerings range from craniofacial and dental implants to orthopedic solutions encompassing bone repair and joint replacement, as well as spinal devices designed for enhanced fusion. Manufacturing methods include melt quenching, sol-gel techniques, and advanced three-dimensional printing, each delivering distinct advantages in porosity control and structural complexity. Design innovations fall into custom implants, patient-specific devices developed through computer-aided design and image-guided planning, and standardized products optimized for broad clinical needs. Performance characteristics such as antibacterial activity, biocompatibility, mechanical strength-distinguishing load-bearing from non-load-bearing uses-and osteoinductivity drive clinician preference and influence product positioning. Lastly, regulatory and research status covers approval stage, clinical trial progression, and preclinical exploration, reflecting a pipeline rich with next-generation compositions and hybrid systems poised for market entry.

Regional Dynamics Driving Bioactive Glass Implant Adoption

Regional dynamics play a pivotal role in shaping adoption patterns and investment flows across the bioactive glass implant industry. In the Americas, established reimbursement frameworks and large hospital networks have accelerated uptake, especially in orthopedic and dental segments, while supportive innovation ecosystems in North America foster partnerships between device makers and research institutions. Across Europe, the Middle East, and Africa, regulatory harmonization efforts and growing awareness of bioactive materials in reconstructive surgery drive demand, yet market maturation varies widely, with Western Europe leading in clinical trial activity and the Middle East embracing rapid deployment in high-profile medical centers. In the Asia-Pacific region, expanding healthcare infrastructure, increasing per-capita healthcare expenditure, and rising prevalence of bone disorders underpin robust growth, with key markets such as China, India, Japan, and South Korea investing heavily in localization and capacity expansion. These regional distinctions highlight the necessity of tailored go-to-market strategies, distribution partnerships, and regulatory navigation plans.

Competitive Landscape and Key Players in Bioactive Glass Implants

The competitive landscape of bioactive glass implants features a diverse mix of established medical device giants and agile specialist innovators. Major players with broad orthopedics and dental portfolios emphasize integration of bioactive glass into comprehensive regenerative platforms, while pure-play glass developers continue to iterate compositions and expand application scope. Collaboration between life science conglomerates and boutique glass technology firms has become commonplace, accelerating access to advanced processing technologies and differentiated formulations. Many leading companies are investing in in-house three-dimensional printing facilities and proprietary sol-gel patent filings, while others pursue licensing agreements to leverage patient-specific or image-guided design capabilities. Strategic acquisitions and joint ventures have further consolidated key capabilities, enabling firms to offer turnkey solutions that address antibacterial protection, osteoinduction, and load-bearing requirements across multiple clinical disciplines. This dynamic ecosystem underscores the importance of innovation pipelines, regulatory expertise, and manufacturing flexibility in maintaining a competitive edge.

Actionable Recommendations for Industry Leaders in Bioactive Glass Implants

Industry leaders can capitalize on emerging opportunities by pursuing several strategic initiatives. First, expanding additive manufacturing capabilities through targeted investments in three-dimensional printing infrastructure will enable rapid prototyping, scalable customization, and cost efficiencies. Second, deepening collaborations with academic centers and contract research organizations to co-develop hybrid compositions and integrate next-generation bioactive agents will fast-track clinical validation. Third, diversifying supply chains by establishing regional production hubs can hedge against trade policy volatility and improve responsiveness to local demand. Fourth, implementing advanced digital workflows for patient imaging, design simulation, and surgical planning will strengthen patient-specific implant offerings and enhance clinical adoption rates. Fifth, engaging proactively with regulators to streamline approval pathways-particularly for combination devices with drug or biologic components-will accelerate time to market. Finally, adopting value-based contracting models with healthcare providers, highlighting long-term cost savings and improved patient outcomes, can solidify reimbursement support and drive premium positioning.

Conclusion: Navigating the Future of Bioactive Glass Implants

The maturation of bioactive glass implants represents a compelling convergence of materials science, clinical innovation, and strategic market dynamics. As borate, phosphate, and silicate compositions prove their versatility across craniofacial, dental, orthopedic, and spinal applications, the industry must navigate evolving trade policies, regulatory requirements, and competitive pressures with agility. Manufacturers that invest in localized production, embrace digital design workflows, and pursue robust clinical evidence will distinguish themselves in a crowded field. Regional nuances-from North America’s reimbursement frameworks to Asia-Pacific’s infrastructure investments-call for nuanced commercialization strategies and partnership models. Moreover, the ongoing shift toward multifunctional implants that combine antibacterial activity, osteoinductive potential, and mechanical resilience will define the next wave of product differentiation. By aligning innovation pipelines with clinician needs and patient outcomes, companies can seize the transformative potential of bioactive glass implants and contribute to a new era of regenerative care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Material Composition
    • Borate Composition
    • Phosphate Composition
    • Silicate Composition
      • Bioactive Silicates
  • Application Area
    • Craniofacial Use
    • Dental Use
    • Orthopedic Use
      • Bone Repair
      • Joint Replacement
    • Spine Use
  • Manufacturing Method
    • Melt Quenching Process
    • Sol Gel Processing
    • Three Dimensional Printing
  • Design Innovation
    • Custom Implants
    • Patient Specific Implants
      • Computer Aided Design
      • Image Guided Design
    • Standard Implants
  • Performance Characteristics
    • Antibacterial Activity
    • Biocompatibility
    • Mechanical Strength
      • Load Bearing
      • Non Load Bearing
    • Osteoinductivity
  • Regulatory and Research Status
    • Approval Stage
    • Clinical Trials
    • Preclinical Research
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • Advanced BioImplants Inc.
  • Arthrex, Inc.
  • Astra Tech AB
  • B. Braun Medical Inc.
  • Bioactive Solutions Inc.
  • Bioglass Innovations LLC
  • BioGlasTech Inc.
  • BioHorizons Inc.
  • Boston Scientific Corporation
  • CeramTec Medical GmbH
  • Dentsply Sirona Inc.
  • DePuy Synthes Companies, Inc.
  • EcoBio Materials Ltd.
  • Globus Medical, Inc.
  • Implant Innovations Ltd.
  • Innovative BioGlass Systems Inc.
  • Johnson & Johnson Medical Devices
  • Medtronic plc
  • Nobel Biocare Services AG
  • NovaBone Technologies Inc.
  • OrthoBio Glass Solutions
  • Osseointechnik Ltd.
  • Planmeca Oy
  • Pohar Medical Technologies
  • Smith & Nephew PLC
  • Straumann Holding AG
  • Stryker Corporation
  • Vita Group
  • Zimmer Biomet Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioactive Glass Implants Market, by Material Composition
8.1. Introduction
8.2. Borate Composition
8.3. Phosphate Composition
8.4. Silicate Composition
8.4.1. Bioactive Silicates
9. Bioactive Glass Implants Market, by Application Area
9.1. Introduction
9.2. Craniofacial Use
9.3. Dental Use
9.4. Orthopedic Use
9.4.1. Bone Repair
9.4.2. Joint Replacement
9.5. Spine Use
10. Bioactive Glass Implants Market, by Manufacturing Method
10.1. Introduction
10.2. Melt Quenching Process
10.3. Sol Gel Processing
10.4. Three Dimensional Printing
11. Bioactive Glass Implants Market, by Design Innovation
11.1. Introduction
11.2. Custom Implants
11.3. Patient Specific Implants
11.3.1. Computer Aided Design
11.3.2. Image Guided Design
11.4. Standard Implants
12. Bioactive Glass Implants Market, by Performance Characteristics
12.1. Introduction
12.2. Antibacterial Activity
12.3. Biocompatibility
12.4. Mechanical Strength
12.4.1. Load Bearing
12.4.2. Non Load Bearing
12.5. Osteoinductivity
13. Bioactive Glass Implants Market, by Regulatory And Research Status
13.1. Introduction
13.2. Approval Stage
13.3. Clinical Trials
13.4. Preclinical Research
14. Americas Bioactive Glass Implants Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Bioactive Glass Implants Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Bioactive Glass Implants Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Advanced BioImplants Inc.
17.3.3. Arthrex, Inc.
17.3.4. Astra Tech AB
17.3.5. B. Braun Medical Inc.
17.3.6. Bioactive Solutions Inc.
17.3.7. Bioglass Innovations LLC
17.3.8. BioGlasTech Inc.
17.3.9. BioHorizons Inc.
17.3.10. Boston Scientific Corporation
17.3.11. CeramTec Medical GmbH
17.3.12. Dentsply Sirona Inc.
17.3.13. DePuy Synthes Companies, Inc.
17.3.14. EcoBio Materials Ltd.
17.3.15. Globus Medical, Inc.
17.3.16. Implant Innovations Ltd.
17.3.17. Innovative BioGlass Systems Inc.
17.3.18. Johnson & Johnson Medical Devices
17.3.19. Medtronic plc
17.3.20. Nobel Biocare Services AG
17.3.21. NovaBone Technologies Inc.
17.3.22. OrthoBio Glass Solutions
17.3.23. Osseointechnik Ltd.
17.3.24. Planmeca Oy
17.3.25. Pohar Medical Technologies
17.3.26. Smith & Nephew PLC
17.3.27. Straumann Holding AG
17.3.28. Stryker Corporation
17.3.29. Vita Group
17.3.30. Zimmer Biomet Holdings, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOACTIVE GLASS IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOACTIVE GLASS IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOACTIVE GLASS IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOACTIVE GLASS IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOACTIVE GLASS IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOACTIVE GLASS IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY BORATE COMPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PHOSPHATE COMPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY BIOACTIVE SILICATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY CRANIOFACIAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DENTAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY BONE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SPINE USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MELT QUENCHING PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SOL GEL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY THREE DIMENSIONAL PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY CUSTOM IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COMPUTER AIDED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY IMAGE GUIDED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY STANDARD IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ANTIBACTERIAL ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY BIOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY LOAD BEARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY NON LOAD BEARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY OSTEOINDUCTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPROVAL STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 126. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 127. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 128. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 129. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 130. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 131. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 132. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 133. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 134. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 135. CHINA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 136. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 137. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 138. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 139. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 140. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 141. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 143. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 144. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 145. INDIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 157. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 158. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 159. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 160. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 161. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 163. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 164. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 165. JAPAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 216. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 217. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 218. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 219. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 220. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 221. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 222. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 223. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 224. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 225. THAILAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 258. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 259. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 260. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 262. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 263. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 266. EGYPT BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 276. FINLAND BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 278. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 279. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 280. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 281. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 282. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 283. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 284. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 285. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 286. FRANCE BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 287. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 288. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 289. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 290. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 291. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 292. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 293. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 294. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 295. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MECHANICAL STRENGTH, 2018-2030 (USD MILLION)
TABLE 296. GERMANY BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY REGULATORY AND RESEARCH STATUS, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY SILICATE COMPOSITION, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY ORTHOPEDIC USE, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PATIENT SPECIFIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL BIOACTIVE GLASS IMPLANTS MARKET SIZE, BY PERFORMANCE CHARACTERISTICS, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL BIOACTIVE GLASS IMPLANTS MAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioactive Glass Implants market report include:
  • Abbott Laboratories
  • Advanced BioImplants Inc.
  • Arthrex, Inc.
  • Astra Tech AB
  • B. Braun Medical Inc.
  • Bioactive Solutions Inc.
  • Bioglass Innovations LLC
  • BioGlasTech Inc.
  • BioHorizons Inc.
  • Boston Scientific Corporation
  • CeramTec Medical GmbH
  • Dentsply Sirona Inc.
  • DePuy Synthes Companies, Inc.
  • EcoBio Materials Ltd.
  • Globus Medical, Inc.
  • Implant Innovations Ltd.
  • Innovative BioGlass Systems Inc.
  • Johnson & Johnson Medical Devices
  • Medtronic plc
  • Nobel Biocare Services AG
  • NovaBone Technologies Inc.
  • OrthoBio Glass Solutions
  • Osseointechnik Ltd.
  • Planmeca Oy
  • Pohar Medical Technologies
  • Smith & Nephew PLC
  • Straumann Holding AG
  • Stryker Corporation
  • Vita Group
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Bioglass for Surgical Implants Market by Application (Dental, Maxillofacial, Orthopedic), End User (Ambulatory Surgical Centers, Clinics, Hospitals), Form, Composition - Global Forecast 2025-2030 - Product Image

Bioglass for Surgical Implants Market by Application (Dental, Maxillofacial, Orthopedic), End User (Ambulatory Surgical Centers, Clinics, Hospitals), Form, Composition - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Bioactive Glass Market by Application (Dentistry, Drug Delivery, Orthopedics), Product Type (13-93, 45S5, 58S), Form, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Bioactive Glass Market by Application (Dentistry, Drug Delivery, Orthopedics), Product Type (13-93, 45S5, 58S), Form, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Bioactive Coating Devices Market by Device Type (Dressings, Implants, Scaffolds), Coating Material (Bioactive Glass, Chitosan, Collagen), Technology, Application, End-User - Global Forecast 2025-2030 - Product Image

Bioactive Coating Devices Market by Device Type (Dressings, Implants, Scaffolds), Coating Material (Bioactive Glass, Chitosan, Collagen), Technology, Application, End-User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Bioceramics Market by Product Type (Alumina, Bioactive Glass, Composites), Application (Bone Grafts, Coatings, Dental Implants) - Global Forecast 2025-2030 - Product Image

Bioceramics Market by Product Type (Alumina, Bioactive Glass, Composites), Application (Bone Grafts, Coatings, Dental Implants) - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Bioactive Materials Market by Material Type (Bioactive Glass, Ceramic, Composite), Functionality (Antimicrobial, Biointeractive, Bioresorbable), Form Factor, Application, End Use Industry - Global Forecast 2025-2030 - Product Image

Bioactive Materials Market by Material Type (Bioactive Glass, Ceramic, Composite), Functionality (Antimicrobial, Biointeractive, Bioresorbable), Form Factor, Application, End Use Industry - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.